BIOMAT Database Logo BIOMAT Database Logo

Changes in individual serum beta2-microglobulin in regular hemodialysis. 2003

T Yamada, and T Satoh

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin

Related Publications

T Yamada, and T Satoh
[Beta2-microglobulin and hemodialysis].
September 1993, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Yamada, and T Satoh
Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients.
February 1999, Pediatric nephrology (Berlin, Germany),
T Yamada, and T Satoh
Alpha-interferon therapy increases serum beta2-microglobulin levels in hemodialysis patients.
November 2001, Clinical nephrology,
T Yamada, and T Satoh
Quantification of cleaved beta2-microglobulin in serum from patients undergoing chronic hemodialysis.
July 2005, Clinical chemistry,
T Yamada, and T Satoh
Rebound kinetics of beta2-microglobulin after hemodialysis.
October 1999, Kidney international,
T Yamada, and T Satoh
Serum beta2-microglobulin in hemodialyzed patients.
January 1978, Nephron,
T Yamada, and T Satoh
Serum beta2-microglobulin in liver disease.
September 1979, Scandinavian journal of clinical and laboratory investigation,
T Yamada, and T Satoh
Letter: Serum beta2-microglobulin and SLE.
January 1976, Arthritis and rheumatism,
T Yamada, and T Satoh
Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
August 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
T Yamada, and T Satoh
Serum beta2-microglobulin in cadmium exposed workers.
September 1978, Pathologie-biologie,
Copied contents to your clipboard!